Cheryl Cohen - Net Worth and Insider Trading

Cheryl Cohen Net Worth

The estimated net worth of Cheryl Cohen is at least $14 Million dollars as of 2024-04-23. Cheryl Cohen is the Director of NantKwest Inc and owns about 270,925 shares of NantKwest Inc (NK) stock worth over $9 Million. Cheryl Cohen is the Chief Commercial Officer of Medivation Inc and owns about 50,878 shares of Medivation Inc (MDVN) stock worth over $4 Million. Cheryl Cohen is also the Director of ImmunityBio Inc and owns about 200,617 shares of ImmunityBio Inc (IBRX) stock worth over $1 Million. Besides these, Cheryl Cohen also holds Immunic Inc (IMUX) . Details can be seen in Cheryl Cohen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cheryl Cohen has not made any transactions after 2021-08-23 and currently still holds the listed stock(s).

Transaction Summary of Cheryl Cohen

To

Cheryl Cohen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cheryl Cohen owns 13 companies in total, including NantKwest Inc () , MEI Pharma Inc () , and Aerpio Pharmaceuticals Inc () among others .

Click here to see the complete history of Cheryl Cohen’s form 4 insider trades.

Insider Ownership Summary of Cheryl Cohen

Ticker Comapny Transaction Date Type of Owner
NantKwest Inc 2020-08-11 director
MEI Pharma Inc 2020-04-10 director
Aerpio Pharmaceuticals Inc 2020-06-24 director
Eledon Pharmaceuticals Inc 2017-06-30 director
Immunic Inc 2018-09-12 director
LadRx Corp 2015-06-23 director
Medivation Inc 2014-02-18 Chief Commercial Officer
ImmunityBio Inc 2021-08-23 director
Aadi Bioscience Inc 2018-06-20 director
Ignyte Acquisition Corp 2021-01-27 director
Ignyte Acquisition Corp 2021-01-27 director
Celldex Therapeutics Inc 2023-06-15 director
Peak Bio Inc 2021-01-27 director

Cheryl Cohen Latest Holdings Summary

Cheryl Cohen currently owns a total of 4 stocks. Among these stocks, Cheryl Cohen owns 270,925 shares of NantKwest Inc (NK) as of August 11, 2020, with a value of $9 Million and a weighting of 62.66%. Cheryl Cohen owns 50,878 shares of Medivation Inc (MDVN) as of October 24, 2013, with a value of $4 Million and a weighting of 29.5%. Cheryl Cohen also owns 200,617 shares of ImmunityBio Inc (IBRX) as of August 23, 2021, with a value of $1 Million and a weighting of 7.84%. The other 1 stocks Immunic Inc (IMUX) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Cheryl Cohen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NK NantKwest Inc 2020-08-11 270,925 32.49 8,802,353
MDVN Medivation Inc 2013-10-24 50,878 81.44 4,143,504
IBRX ImmunityBio Inc 2021-08-23 200,617 5.49 1,101,387
IMUX Immunic Inc 2018-09-12 0 1.24 0

Holding Weightings of Cheryl Cohen


Cheryl Cohen Form 4 Trading Tracker

According to the SEC Form 4 filings, Cheryl Cohen has made a total of 1 transactions in NantKwest Inc (NK) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in NantKwest Inc is the sale of 30,000 shares on August 11, 2020, which brought Cheryl Cohen around $298,800.

According to the SEC Form 4 filings, Cheryl Cohen has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 100,000 shares on October 24, 2013, which brought Cheryl Cohen around $3 Million.

According to the SEC Form 4 filings, Cheryl Cohen has made a total of 2 transactions in ImmunityBio Inc (IBRX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in ImmunityBio Inc is the sale of 24,777 shares on August 23, 2021, which brought Cheryl Cohen around $249,504.

More details on Cheryl Cohen's insider transactions can be found in the Insider Trading History of Cheryl Cohen table.

Insider Trading History of Cheryl Cohen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cheryl Cohen Trading Performance

GuruFocus tracks the stock performance after each of Cheryl Cohen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cheryl Cohen is 21.55%. GuruFocus also compares Cheryl Cohen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cheryl Cohen within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Cheryl Cohen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Cheryl Cohen

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 36.05 21.55 25.97 -23.29 -14.83 -64.67
Relative Return to S&P 500(%) 35.2 29.64 24.98 -26.58 -26 -73.34

Cheryl Cohen Ownership Network

Ownership Network List of Cheryl Cohen

No Data

Ownership Network Relation of Cheryl Cohen


Cheryl Cohen Owned Company Details

What does NantKwest Inc do?

Who are the key executives at NantKwest Inc?

Cheryl Cohen is the director of NantKwest Inc. Other key executives at NantKwest Inc include director & See remarks Barry J. Simon , Chief Financial Officer Sonja Nelson , and director & 10 percent owner & Chairman and CEO Patrick Soon-shiong .

NantKwest Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NantKwest Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NantKwest Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NantKwest Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NantKwest Inc Insider Transactions

No Available Data

Cheryl Cohen Mailing Address

Above is the net worth, insider trading, and ownership report for Cheryl Cohen. You might contact Cheryl Cohen via mailing address: C/o Medivation, Inc., 201 Spear St., 3rd Floor, San Francisco Ca 94105.

Discussions on Cheryl Cohen

No discussions yet.